Grants & Giving
Grants & Giving
At Exelixis, making a difference goes beyond developing medicines for patients. We support like-minded organizations that are dedicated to improving cancer education, outreach and advocacy. Through our giving initiatives, we extend our impact and create partnerships to benefit patients as well as the healthcare providers and researchers championing their care. We approach educational requests, sponsorships, charitable contributions and volunteerism with a generous spirit of caring, knowing that together we can do more for the communities we serve. To visit our Exelixis Request Management System, or to submit a grant, please click here.
Areas of Support
Exelixis currently supports grants and giving initiatives that fall within certain key categories that are detailed below:
- Educational Requests: Support for clinical, technical, and scientific education programs or activities with an oncology focus including, but not limited to, funding for live events such as educational conferences, symposia, or meetings, enduring educational materials, and web-based or online educational activities.
- Sponsorships: General funding support for various scientific and educational activities or programs through sponsorship of, and participation in, scientific meetings or conferences, for which Exelixis receives tangible benefits in exchange for such support. Sponsorships requests must be submitted 60 days prior to the program start date.
- Charitable Contributions: Monetary charitable contributions to support 501(c)3 and 501(c)6 non-profit organizations’ initiatives in the focus areas of oncology or cancer awareness, patient education and advocacy. Charitable contribution requests must be submitted at least 60 days prior to the program start date.
Exelixis will consider support within the therapeutic area of oncology, with a focus on renal cell carcinoma and hepatocellular carcinoma, but consideration is also given to thyroid, bladder and lung cancers. Programs in other cancer indications or in therapeutic areas outside of oncology may be considered. Please note that not all programs can be approved, even if the request relates to the above therapeutic area and disease states.